BiotechTube
Home/STALICLA/Dr. Carine de Beaufort
DC

Dr. Carine de Beaufort

Chief Medical Officer

STALICLA

Therapeutic Areas

Neurodevelopmental DisordersAutism Spectrum DisorderBrain Disorders

STALICLA Pipeline

DrugIndicationPhase
STP1Autism Spectrum Disorder (specific subgroup)Phase 2
STP2Autism Spectrum Disorder (specific subgroup)Preclinical

Leadership Team at STALICLA

LD
Lynn Durham
Founder & CEO
DC
Dr. Carina R. Bichsel
Chief Operating Officer
DP
Dr. Paul Wang
Head of Development
View full STALICLA profile